Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (600613) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.

Why is Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. ?

Poor Management Efficiency with a low ROCE of 3.19%

The company has been able to generate a Return on Capital Employed (avg) of 3.19% signifying low profitability per unit of total capital (equity and debt)

Poor long term growth as Net Sales has grown by an annual rate of 0.43% and Operating profit at -1.21% over the last 5 years

Negative results in Mar 25

NET SALES(HY) At CNY 951.21 MM has Grown at -19.97%
OPERATING CASH FLOW(Y) Lowest at CNY 137.26 MM
INTEREST COVERAGE RATIO(Q) Lowest at 847.34

With ROE of 2.67%, it has a attractive valuation with a 1.32 Price to Book Value

Over the past year, while the stock has generated a return of -7.70%, its profits have fallen by -0.2%
At the current price, the company has a high dividend yield of 2.4

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -7.70% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. for you?

Medium Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.

-7.7%

0.74

29.81%

China Shanghai Composite

14.77%

1.01

14.58%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

0.43%

EBIT Growth (5y)

-1.21%

EBIT to Interest (avg)

-11.55

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.25

Sales to Capital Employed (avg)

0.84

Tax Ratio

25.83%

Dividend Payout Ratio

112.19%

Pledged Shares

Institutional Holding

ROCE (avg)

3.19%

ROE (avg)

1.97%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.32

EV to EBIT

28.54

EV to EBITDA

14.89

EV to Capital Employed

1.41

EV to Sales

1.37

PEG Ratio

Dividend Yield

2.35%

ROCE (Latest)

4.93%

ROE (Latest)

2.67%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Moving Averages

Mildly Bearish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bullish

OBV

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company

NET PROFIT(HY)

At CNY 26.72 MM has Grown at 82.07%

ROCE(HY)

Highest at 2.64%

CASH AND EQV(HY)

Highest at CNY 1,596.57 MM

-17What is not working for the Company

NET SALES(HY)

At CNY 951.21 MM has Grown at -19.97%

OPERATING CASH FLOW(Y)

Lowest at CNY 137.26 MM

INTEREST COVERAGE RATIO(Q)

Lowest at 847.34

INVENTORY TURNOVER RATIO(HY)

Lowest at 4.74%

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.97%

OPERATING PROFIT(Q)

Lowest at CNY 21.05 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 4.47 %

Here's what is working for Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.

Net Profit

At CNY 26.72 MM has Grown at 82.07%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

Cash and Eqv

Highest at CNY 1,596.57 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Here's what is not working for Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.

Net Sales

At CNY 951.21 MM has Grown at -19.97%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very negative

Net Sales (CNY MM)

Interest Coverage Ratio

Lowest at 847.34 and Fallen

In each period in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Operating Cash Flow

Lowest at CNY 137.26 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Operating Profit

Lowest at CNY 21.05 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at 4.47 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Inventory Turnover Ratio

Lowest at 4.74%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio

Lowest at 2.97%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio